Concepedia

Author

Ingo Diel

Heidelberg UniversityORCID

Also Known As

Diel, I., Diel, Ingo J., I Diel, I J Diel, I. Diel, I. J. DIEL, I. J. Diel, I.J Diel, I.J. DIEL, I.J. Diel

233

Publications

10.7K

Citations

43

H-Index

87

Concepts

All Affiliations

Heidelberg UniversityUniversity Hospital HeidelbergPraxis für Hämatologie und OnkologieUniversité Libre de BruxellesInstitut Jules Bordet
ID

About

Ingo Diel is an author at Heidelberg University specializing in medicine, breast cancer, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

24

38

3.3K

2

Health Sciences

10

10

867

3

Biostatistics

2

2

92

4

Engineering

1

1

122

5

Public Health

1

1

134

Ingo Diel

×

62

Publications

7.8K

Citations

35

H-Index

YearCitations

A Pooled Analysis of Bone Marrow Micrometastasis in Breast Cancer

Stephan Braun, Florian D. Vogl, Bjørn Naume,

New England Journal of Medicine

2005

1.4K

Reduction in New Metastases in Breast Cancer with Adjuvant Clodronate Treatment

Ingo Diel, Erich‐Franz Solomayer, Serban Dan Costa,

New England Journal of Medicine

1998

808

Micrometastatic Breast Cancer Cells in Bone Marrow at Primary Surgery: Prognostic Value in Comparison With Nodal Status

Ingo Diel, M. Kaufmann, Serban Dan Costa,

JNCI Journal of the National Cancer Institute

1996

487

Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastases

Jean‐Jacques Body, Ingo Diel, E.D. Kreuser,

Annals of Oncology

2003

414

Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis

Erich‐Franz Solomayer, Ingo Diel, G. Meyberg,

Breast Cancer Research and Treatment

2000

355

Oral ibandronate reduces the risk of skeletal complications in breast cancer patients with metastatic bone disease: results from two randomised, placebo-controlled phase III studies

Jean‐Jacques Body, Ingo Diel, M. Lichinitzer,

British Journal of Cancer

2004

334

Detection of tumor cells in bone marrow of patients with primary breast cancer: a prognostic factor for distant metastasis.

Ingo Diel, M. Kaufmann, R. Goerner,

Journal of Clinical Oncology

1992

286

Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells

Elin Borgen, Bjørn Naume, Jahn M. Nesland,

Cytotherapy

1999

265

Therapy of human tumors in NOD/SCID mice with patient-derived reactivated memory T cells from bone marrow

Markus Feuerer, Philipp Beckhove, Lianhua Bai,

Nature Medicine

2001

264

Adjuvant oral clodronate improves the overall survival of primary breast cancer patients with micrometastases to the bone marrow—a long-term follow-up

Ingo Diel, Anja Jäschke, Erich‐Franz Solomayer,

Annals of Oncology

2008

226

Page 1